OBJECTIVE: Angiotensin II (Ang II) receptor blockers have been reported to contribute to cytoprotective effects in various organs. However, the role of renin-angiotensin system (RAS) in modulation of the inflammatory bowel disease (IBD) remains unclear. In this study we assessed the role of angiotensin II type 1a (AT1a) receptor on the outcome of dextran sulfate sodium (DSS)-induced acute colitis by employing AT1a receptor deficient mice. MATERIALS AND METHODS: The acute colitis was induced in wild type (WT) and AT1a receptor deficient mice by giving orally 3% DSS in drinking water for 7 days. RESULTS: Induction of DSS colitis resulted in up-regulation of Ang II and AT1a receptor in the colonic mucosa of WT mice. In parallel, loss of body weight, an increase in disease activity index (DAI), and the shortening of colon were found in DSS-challenged WT mice. In addition, an increase in thiobarbituric acid (TBA)-reactive substances and myeloperoxidase (MPO) activity, along with the up-regulation of tumor necrosis factor (TNF)-alpha were detected in the colonic mucosa of DSS-challenged WT mice. The endpoints mentioned above were significantly ameliorated in DSS-challenged AT1a receptor deficient mice. CONCLUSIONS: RAS is involved in the pathophysiology of DSS-induced colitis and AT1a receptor may be a novel therapeutic target for the treatment of IBD.
OBJECTIVE:Angiotensin II (Ang II) receptor blockers have been reported to contribute to cytoprotective effects in various organs. However, the role of renin-angiotensin system (RAS) in modulation of the inflammatory bowel disease (IBD) remains unclear. In this study we assessed the role of angiotensin II type 1a (AT1a) receptor on the outcome of dextran sulfate sodium (DSS)-induced acute colitis by employing AT1a receptor deficient mice. MATERIALS AND METHODS: The acute colitis was induced in wild type (WT) and AT1a receptor deficient mice by giving orally 3% DSS in drinking water for 7 days. RESULTS: Induction of DSScolitis resulted in up-regulation of Ang II and AT1a receptor in the colonic mucosa of WT mice. In parallel, loss of body weight, an increase in disease activity index (DAI), and the shortening of colon were found in DSS-challenged WT mice. In addition, an increase in thiobarbituric acid (TBA)-reactive substances and myeloperoxidase (MPO) activity, along with the up-regulation of tumor necrosis factor (TNF)-alpha were detected in the colonic mucosa of DSS-challenged WT mice. The endpoints mentioned above were significantly ameliorated in DSS-challenged AT1a receptor deficient mice. CONCLUSIONS: RAS is involved in the pathophysiology of DSS-induced colitis and AT1a receptor may be a novel therapeutic target for the treatment of IBD.
Authors: Sarah E Sansom; Gerard J Nuovo; Mickey M Martin; Sainath R Kotha; Narasimham L Parinandi; Terry S Elton Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-06-17 Impact factor: 4.052
Authors: Lei He; Jie Du; Yinyin Chen; Chunyan Liu; Min Zhou; Sarbani Adhikari; David T Rubin; Joel Pekow; Yan Chun Li Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-04-17 Impact factor: 4.052
Authors: John J Byrnes; Stefan Gross; Courtney Ellard; Kelly Connolly; Stephen Donahue; Dominic Picarella Journal: Inflamm Res Date: 2009-06-11 Impact factor: 4.575
Authors: Jia Wang; Liang Han; James Sinnett-Smith; Li-Li Han; Jan V Stevens; Nora Rozengurt; Steven H Young; Enrique Rozengurt Journal: Am J Physiol Cell Physiol Date: 2016-01-06 Impact factor: 4.249
Authors: Urszula Dougherty; Reba Mustafi; Farhana Sadiq; Anas Almoghrabi; Devkumar Mustafi; Maggi Kreisheh; Sumana Sundaramurthy; Weicheng Liu; Vani J Konda; Joel Pekow; Sharad Khare; John Hart; Loren Joseph; Alice Wyrwicz; Gregory S Karczmar; Yan Chun Li; Marc Bissonnette Journal: Clin Cancer Res Date: 2014-09-11 Impact factor: 12.531